Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-11-14

Clinical Trial Update: Local Betamethasone Versus Triamcinolone Injection in Management of Thyroid Eye Disease [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 trial comparing local betamethasone versus triamcinolone injection for thyroid eye disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Triamcinolone (triamcinolone)
  • betamethasone (betamethasone)

Snippet

Sponsor: Assiut University | Conditions: Thyroid Eye Disease | Phase 2, Phase 3 | Status: COMPLETED